Previous Page  18 / 25 Next Page
Information
Show Menu
Previous Page 18 / 25 Next Page
Page Background

Vascular Surgery 2019

Journal of Vascular and Endovascular Therapy

ISSN: 2573-4482

Page 48

March 28-29, 2019

Rome, Italy

Vascular Surgery

4

th

Edition of World Congress & Exhibition on

Congenital vascular malformations: features of diagnosis

and complex treatment

Chernukha L M, O V Kashyrova, A O Guch, G G Vlaykov, О A Vlasenko, I V Alt-

man, V A Kondratyuk

and

I V Gomolyako

National Institute of Surgery and Transplantology, Ukraine

Chernukha L M et al., J Vasc Endovasc Therapy 2019, Volume 4

DOI: 10.21767/2573-4482-C1-005

Introduction:

Congenital

vascular

malformations

(CVM) occur in 1.5-10% of the total population. Various

manifestations of CVM cause difficulties in diagnosis and

treatment, resulting in disability and sometimes, death of

the patient.

Methods:

The data of 630 patients with CVM (period

2005-2016) were analysed, females predominated (55%),

and average age was 25.5. Ultrasound duplex scanning,

selective arteriography, phlebography, multidetected

computed

tomography,

pathomorphological

and

immunohistochemical studies (proliferation markers

VEGF, Ki-67), study of the hemostasis (D-dimer, soluble

fibrin, fibrinogen) and fibrinolytic system (protein C) were

investigated.

Results:

The source of proliferation of both forms of CVM

(venous and arteriovenous (AV)), given the level of VEGF

and Ki-67 expression, is precisely the microcirculatory

vasculature, due to the presence of existing AV

microfistulas. It was discovered the significant activation

of coagulation capacity in preoperative period in patients

with AV CVM (23): 9 (39%) patients had significantly

increased plasma fibrinogen content (from 3.7 to 7.2 g/l),

10 (43.5%) - soluble fibrin (from 3.6 to 50 μg/ml), in 7

(30.4%) - D-dimer (from 119.3 to 1608.3 ng/ml); the activity

of protein C in 95% of patients corresponded to the norm/

changes in the postoperative period depended on the

clinical-anatomical form of CAVM and type (radicality) of

the intervention. Treatment strategy include: Endovascular

methods (embolization with the use of non-spherical PVA

particles) during preoperative stage and combination of

surgical, embolization, laser and sclerotic methods in

perioperative stage; Correction of AV shunting separately

or in conjunction with venous hypertension correction;

Correction of secondary venous hypertension in superficial

and/or deep venous systems; Correction of lymphatic

outflow (lymphodrenation, lymphangioplasty, and lipo-

lympho-aspiration, lymphovenous anastomoses) and; In

cases of severe pain syndrome neurolysis with fascicullary

dissection were performed.

Conclusions:

The introduced pathogenically based

approach allowed obtaining satisfactory results in 94.4% of

patients.

Recent Publications

1. Chernukha L et al. (2016) Epidemiological

aspects of comorbidity of lower limbs chronic

venous disease (CVD) and haemorrhoids: the

results of detect-duo. Іnt Angіol. 35(1-2):83.

2. L M Chernukha, O V Kashyrova, A O Guch, G

G Vlaykov, O A Vlasenko, V A Kondratuk and

I V Gomolyako (2017) Congenital vascular

malformations: features of diagnosis and

treatment (2017) The Hungerian Journal of

Vascular Diseases XXIV(3):17-18.